Therapy-Related Myeloid Neoplasms in Patients Treated for Hodgkin Lymphoma

Abstract

Hodgkin lymphoma (HL) is a malignancy of the lymphatic system with an incidence of 2-3/100.000/year in developed countries. With modern multi-agent chemotherapy protocols optionally combined with radiotherapy (RT), 80% to 90% of HL patients achieve long-term remission and can be considered cured. However, current standard approaches bear a considerable risk… (More)
DOI: 10.4084/MJHID.2011.046

Topics

2 Figures and Tables

Slides referencing similar topics